AU2000228211A1 - A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells - Google Patents

A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells

Info

Publication number
AU2000228211A1
AU2000228211A1 AU2000228211A AU2821100A AU2000228211A1 AU 2000228211 A1 AU2000228211 A1 AU 2000228211A1 AU 2000228211 A AU2000228211 A AU 2000228211A AU 2821100 A AU2821100 A AU 2821100A AU 2000228211 A1 AU2000228211 A1 AU 2000228211A1
Authority
AU
Australia
Prior art keywords
increasing
stem cells
embryonic stem
embryoid bodies
vitro production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000228211A
Inventor
Yves Chicheportiche
Christiane Ody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2000228211A1 publication Critical patent/AU2000228211A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2000228211A 2000-03-09 2000-03-09 A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells Abandoned AU2000228211A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2000/000246 WO2001065928A1 (en) 2000-03-09 2000-03-09 A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells

Publications (1)

Publication Number Publication Date
AU2000228211A1 true AU2000228211A1 (en) 2001-09-17

Family

ID=11003891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000228211A Abandoned AU2000228211A1 (en) 2000-03-09 2000-03-09 A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells

Country Status (2)

Country Link
AU (1) AU2000228211A1 (en)
WO (1) WO2001065928A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1005702B1 (en) * 2010-12-21 2020-02-04 Inprenha Biotecnologia E Desenvolvimento Avancado Ltda Me method to increase the rate of embryo implantation in the maternal uterus in mammals, use of an effective amount of a beta-galactoside-binding lectin or derivatives thereof and product

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008215A1 (en) * 1991-10-16 1993-04-29 Cetus Oncology Corporation Secreted mac-2-binding glycoprotein
WO1993016183A1 (en) * 1992-02-07 1993-08-19 The Board Of Trustees Of The Leland Stanford Jr. University Cyclophilin associated membrane proteins dna sequences
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations

Also Published As

Publication number Publication date
WO2001065928A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2002258477A1 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
IL208748A0 (en) Method of making embryoid bodies from primate embryonic stem cells
AU2002356749A1 (en) Process for the production of polypeptides in mammalian cell cultures
IL149175A (en) Methods for production of pluripotent cells
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
EP1424389A4 (en) Process for preparing hematopoietic stem cells
AU2001267900A1 (en) Process for the prodcution of glycerides with lipases
AU6842001A (en) Pluripotent mammalian cells
AU2002301347A1 (en) Embryonic stem cells and neural progenitor cells derived therefrom
AU2003295444A1 (en) Methods for in vitro expansion of hematopoietic stem cells
AU2002219008A1 (en) Method for decellularising foreign material for the production of bioprostheses
AU1786899A (en) Industrial production of meat from (in vitro) cell cultures
WO2000070021A3 (en) Differentiated human embryoid cells and a method for producing them
AU2002237729A1 (en) Process for the production of polycarbonate
WO2001014566A3 (en) Enzymatic synthesis of deoxyribonucleosides
IL141735A0 (en) Method of culturing embryonic stem cells
AU2002352100A1 (en) Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells
HK1048650A1 (en) Methods for enhancing the production of cytokines in cell cultur e
AU2001277545A1 (en) Process for the production of 2-hydroxy-4-methylmercaptobutyric acid
WO2002064666A3 (en) Substrates containing polyphosphazene as matrixs and with a microstructured surface
AU2748799A (en) Process for the production of a shaped article
AU2000228211A1 (en) A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells
AU2002234051A1 (en) Process for the production of polycarbonate
AU2001236057A1 (en) Process for the production of optically active beta-amino alcohols
AU3191700A (en) Process for producing 5-amino-8- alkylquinolo necarboxylic acid derivatives and intermediates in the production thereof